Neurolase: Making brain tumour surgery safer through the Cancer Tech Accelerator
As part of the Cancer Tech Accelerator, we’ve awarded Neurolase £50,000 to advance a laser-based tool that could help make brain tumour surgery more precise. The post Neurolase: Making brain tumour…
Read the full articleYou might also wanna read
Allen Institute launches $400M Brain Health accelerator to develop genetic therapies for neurodegenerative diseases
The Allen Institute in Seattle says scientists have now learned enough about how the brain works to start fixing it when it breaks.
npr.org·1mo ago
AI tool analyzes tumour images to guide treatment for common brain cancer
Researchers have developed an Artificial Intelligence (AI) tool that could one day help tailor treatment for meningioma.
thebraintumourcharity.org·1mo agoAI tool analyzes tumour images to guide treatment for common brain cancer
Researchers have developed an Artificial Intelligence (AI) tool that could one day help tailor treatment for meningioma.
thebraintumourcharity.org·1mo ago
Laser treatment helps brain cancer patient surpass 7-year survival milestone
A patient diagnosed with glioblastoma, an aggressive form of terminal brain cancer, is marking seven years since his diagnosis.
NIH funding cuts threaten the cancer research that saved my life, says mother of two
The Trump administration proposes cutting $6 billion from the National Institutes of Health. Philanthropy cannot replicate the scale of gove
ms.now·1mo ago
UK Quantum Biomedical Hub Awarded £902,000 for Clinical Sensing and Imaging Hardware Development
The UK National Quantum Biomedical Research Hub (Q-BIOMED) has been awarded £902,000 ($1.2 million USD) from the Engineering and Physical Sc
iq.fp2.dev·1mo ago
Brain-Computer Interface Startup Coherence Neuro Tests Cancer-Detecting Implant in Three Human Patients
Coherence Neuro has started testing a brain-computer interface that could one day use electrical stimulation to prevent tumors from growing.
wired.com·23d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.